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Background/aim: The study aims to evaluate the usage of gold weight implants and monitor complaints and comfort of patients.
Materials and methods: A hundred and ninety-one implantations performed between January 2009 and January 2019 were analyzed.
Seventy-eight patients included in this study The average age of the patients was 51.3 ± 14.5 years. Forty-five (57.7%) of them were male
and 33 (42.3%) female. Patient satisfaction was measured with a questionnaire containing the most common complaints related to gold
weight in the literature through telephone surveys.
Results: The average follow-up time was 74.5 months. Ninety-three-point-five percent of subjects had operational causes, among
which the most widespread was acoustic neuroma (44.9%). The average time between facial paralysis and implantation was 141.1
days. Implantation was performed 26.6 days on average after acoustic neuroma surgery and 3.2 days on average after temporal zone
malignancy surgery. Thirty-eight patients had their implants removed over either complication (n = 14) or recovery (n = 24). Recovery
was the fastest after facial nerve decompression (mean= 4.75 ± 3.6 (2–10) months) and the slowest after 7–12 cranial nerve transfer
(mean= 18.3 ± 8.2 (3–31) months). Twenty-six-point-nine percent (n = 21) of patients had complications, of which the most common
was extrusion (n = 10). The overall satisfaction rate was 88.5% with the highest in visual acuity and the lowest in continuous requirement
for artificial tear.
Conclusion: The gold weight implantation is an effective, reversible, and easy procedure significantly reducing complaints regarding
paralytic lagophthalmos. Early implementation may be beneficial for ocular complications. A dynamic facial reanimation could
terminate need of implant.
Key words: Gold weight implant, facial nerve paralysis, facial nerve, facial reanimation, acoustic neuroma

1. Introduction
Advanced peripheral facial paralysis that affects eye
closure function is frequently seen after otologic,
neurotologic, and lateral skull base surgeries [1]. In
addition, cholesteatoma, some malignant tumors, and
idiopathic facial paralysis (Bell’s palsy) can cause loss of
eye closure function [2]. The reason for the loss of eye
closure function is the loss of innervation and function
of the orbicularis oculi muscle. Moreover, the loss of
parasympathetic innervation of lacrimal gland disturbs
production of tear and the loss of eyelid tone may lead to
eversion of the eyelid. On the other hand, levator palpebrae
superior muscle that is still functioning ensures the eye to
remain open. This condition is called lagophthalmos and
accompanied by poor lid closure, incomplete blinking,
lower eyelid ectropion, and eye dry out. This could lead
to keratitis and corneal abrasion, followed by loss of
vision, and eventually blindness [1,3]. Management of

lagophthalmos caused by facial paralysis includes various
surgical and non-surgical methods. Eye-patching and
lubricant drops could be beneficial when spontaneous
recovery is anticipated in the short term. In case there is
permanent damage to facial nerve or no expectation of a
quick recovery, surgical management should be employed.
Surgical managements are grouped as dynamic and static
procedures. Dynamic procedures involve nerve repair and
muscle transposition whereas static procedures consist of
temporary or permanent tarsorrhaphy, mullerectomy, and
lid loading. Lid loading with gold weight is an effective
and widely-used method [4]. Its low complication rates,
easy application, and reversibility have contributed to
the popularity of the method. Gold is the most preferred
material in lid loading due to its nonallergic properties,
malleability, high density, and color match for the skin [5].
Thanks to inert nature of gold, allergy has been reported in
only one case [6].
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Even if blink reflex could not be reestablished,
voluntary closure of eyelid could be restored. The method
depends on the gravitational action of the weight against
force vector of levator palpebrae superioris muscle. Since
it is a mechanical method rather than being a physiological
procedure, situations such as sense of foreign body, eye
dryness, blurred vision, and extrusion of the implant that
negatively affect the quality of life may occur in the long
term. The aim of the study is to evaluate the usage of gold
weight implants and monitor the complaints and comfort
of patients.
2. Patients and method
A hundred and ninety-one gold weight implantations
performed between January 2009 and January 2019 at our
otorhinolaryngology clinic were analyzed retrospectively.
In addition to the patients who had passed away by the
time of the study, those who had undergone the following
operations were excluded: a previous eyelid surgery such
as blepharoplasty and levator resection that may have
caused a scar in the upper lid, a revision of gold weight
implantation. Patients with inadequate follow-up data
were also excluded. Ninety-one patients who met the
criteria were interviewed by phone. Seventy-eight patients
who answered the questionnaire were included in this
study.
Patients’ demographic data, causes of facial paralysis,
durations of gold weight usage, causes of extraction of
implant, and complications encountered were obtained
from patient files. To evaluate the factors that could
influence the overall satisfaction, we conducted a
questionnaire containing the most common complaints
related to gold weight in the literature [7–10]. The patient
satisfaction questionnaire was conducted by phone call. The
questions answered by the voluntary patients are shown in

Table 1. For each question (symptom), patients chose one
of the following answers: highly dissatisfied, dissatisfied,
normal, satisfied, and highly satisfied. Moreover, patients
were asked about overall satisfaction. The study was
approved by the local ethical committee of Gazi University
(91610558-604.01.02-). Statistical analysis was performed
through IBM SPSS Statistics v: 22.0 (IBM Corp., Armonk,
NY, USA). Kaplan–Meier survival estimate was conducted
for extrusion and recovery. Descriptive data were presented
as number (n) and percentage (%).
2.1. Surgical method
Initially, the proper weight of the gold planned to be
implanted was measured meticulously. To determine the
ideal weight, each patient sat in an upright position and
weights ranging from 1.2 g to 2.2 g were incrementally
placed on upper lid till sufficient eye closure was acquired.
All surgeries were performed by an otorhinolaryngologist.
All of the procedures were implemented under local
anesthesia and 1½ cm incision was made on upper eyelid
crease. After skin incision, orbicularis oculi muscle was
dissected and a pocket 2 mm above the upper eyelash
margin was created between orbicularis oculi muscle
and tarsal plate. A gold weight, curved according to the
shape of eye globe with two holes on the corners and one
on the opposite edge, was inserted into the pocket. The
gold weight was fixed to the tarsal plate with 6.0 prolene
suture (Ethicon US, LLC). Orbicularis oculi muscle and
skin incisions were sutured respectively with 5.0 monocryl
suture (Ethicon US LLC). A dressing was made with sterile
strips. All the patients were discharged on the same day as
the operation.
3. Results
The average age of the patients was 51.3 ± 14.5 years.
Forty-five (57.7%) of them were male and 33 (42.3%)

Table 1. Questionnaire of patients’ perspectives on ocular symptoms.
Level of satisfaction
Questions (Symptoms)

Highly dissatisfied (%)

Dissatisfied (%) Normal (%)

Satisfied (%)

Highly satisfied (%)

Absence of pain

1.3

1.3

5.1

21.8

70.5

Absence of tearing

-

5.1

7.7

32.1

55.1

Absence of redness

1.3

1.3

9.0

28.2

60.3

Absence of foreign body sensation

-

3.8

7.7

21.8

66.7

Visual acuity

1.3

-

3.8

15.4

79.5

Absence of need for artificial tear

7.7

10.3

38.5

33.3

10.3

Daytime eye closing ability

-

1.3

11.5

35.9

51.3

In-sleep eye closing ability

-

3.8

10.3

34.6

51.3

Aesthetical appearance

1.3

7.7

9.0

42.3

39.7
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female (Table 2). The average follow-up time was 74.5
months. The causes of facial paralysis were shown in Table
3. Surgery was the main cause of paralysis and comprised
93.5% of the eyelid loading indications. The average time
between facial paralysis and gold weight implantation was
147.1 days. The average intervals for each indication were
shown in Table 3.
The gold weight implant of 38 patients had been
removed by the time of the questionnaire (Table 4).
Fourteen of these removal procedures had resulted from
complications such as extrusion (n = 10), migration (n =
2), and infection (n = 2). Twenty-four patients had their
implants removed over recovery (either spontaneous or
through facial reanimation). Four of these removals had
been caused by spontaneous recovery of facial nerve
function. The remaining 20 patients had undergone a
successful facial reanimation procedure before removal:
thirteen of them had had 7–12 cranial nerve transfer
surgery, four facial nerve decompression surgery, and
three facial nerve repair with cable graft. For all 38
patients, the average duration between the implantation
and the removal was 16.0 ± 13.2 months (1–72). Durations
concerning removal by complication and removal by
recovery were 18.3 ± 18.8 (1–72) and 14.6 ± 8.7 (2–31)
months, respectively and the difference was not statistically
significant. This figure was 18.3 ± 8.2 (3–31) months for
7–12 cranial nerve transfer surgery, 17.0 ± 11.2 (10–30)
months for cable graft, 4.75 ± 3.6 (2–10) months for facial
nerve decompression, and 11.0 ± 1.6 (9–13) months for
spontaneous recovery. A Kaplan–Meier survival estimate
conducted with the patient who had their implants
removed due to a successful facial reanimation procedure
showed that half of the removals due to recovery occurred
in a year after implantation (Figure 1).
A complication occurred in 26.9% (n = 21) of the
patients (Table 5). Extrusion of the implant was the most
common complication (n = 10). The average time of
extrusion was 20.4 ± 20.4 (4–72) months. Kaplan–Meier
survival estimates conducted with patients who were
complicated with extrusion of the gold weight showed that
about 80% of this complication occurred within two years
after the implantation (Figure 2). The other complications
were dislocation and migration of the implant (5.1%, n =
4), infection (5.1%, n = 4), residual lagophthalmos (2.6%,
n = 2), and ectropion of the upper eyelid (1.3%, n = 1).
The results of the patient satisfaction questionnaire
were shown in Table 1. Forty patients had their implants
in situ at the time of the questionnaire. Visual acuity and
pain were the symptoms that received the highest rates
of satisfaction: 70.5% of the patients were highly satisfied
with the absence of pain while 79.5% of them were highly
satisfied with their visual acuity. Artificial tear usage had
the lowest complacency rate: Only 10.3% of the patients
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Table 2. Demographics and time intervals.
General information
Age

51.3 ± 14.5 years

Sex
Male

45 (57.7%)

Female

33 (42.3%)

Side
Right

42 (54%)

Left

36 (46%)

Status
Present

40 (51.3%)

Complication related removal

14 (18%)

Recovery related removal

24 (30.7%)

Interval between FP-GWI

147.1 ± 817.7 days (2–7200)

Interval between GWI-removal 16.0 ± 13.2 (1–72) months
Complication related

18.3 ± 18.8 (1–72) months

Recovery related

14.6 ± 8.7 (2–31) months

Ongoing usage time

69.6 ± 29.0 (15–131) months

Follow-up time

74.5 months

GWI: Gold weight implantation, FP: Facial paralysis.

were highly satisfied with the absence of need for artificial
tear whereas 7.3% of them were highly dissatisfied with
needing to use it. 9% of the patients were not pleased with
aesthetical appearance of the implant. When the patients
were asked about their gladness of gold weight implant
broadly, 88.5% of them (n = 69) declared contentment.
4. Discussion
The present study investigated the role of lid loading
with gold weight in the management of paralytic
lagophthalmos and assessed patients’ perspectives on
ocular symptoms. Although lid loading methods provide
voluntary eye closure with the help of gravity, blinking
reflex could not be reestablished. Even if these methods
do not offer a physiological recovery, high rates of success
and satisfaction have been presented in the literature [11].
Kelley et al. reported that 72% of patients in their study
felt more comfortable after lid loading [12]. Misra et al.
noted that the majority of the participants (88%) stated
improvement [9]. In a study by May, which is one of the
largest series in the literature, a success rate of 90% was
observed [11]. Rofagha reported that 97% of the operations
of eyelid loading were successful in providing improved
protection for the patient’s eye and decreasing daily care
needs [13]. In the present study, the overall satisfaction
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Table 3. Causes of lagophthalmos and durations between facial
paralysis and gold weight implantation.

Table 4. Causes of removal of the gold weight implants.
Cause of removal

n

%

7–12 Anastomosis

13

34.2

26.6

Extrusion

10

26.3

4

10.5

Indications

n

%

Time
(day)

Acoustic neuroma

35

44.9

Cholesteatoma

11

14.1

274.2

Spontaneous gain of function

Temporal zone malignity

6

7.7

3.2

Decompression of facial nerve

4

10.5

3

7.9

Parotid gland malignity

5

6.4

88.3

Facial nerve repair with cable graft

Mastoid bone surgery

4

5.1

58.7

Migration

2

5.3

Malignant pontocerebellar angle tumor 4

5.1

37.5

Infection

2

5.3

Traumatic temporal bone fracture

3

3.8

178.6

TOTAL

38

100

Idiopathic peripheral facial palsy

2

2.6

~

Facial Schwannoma

2

2.6

27.0

Meningioma

2

2.6

106.5

Glomus Jugulotympanicum

1

1.3

30.0

Chordoma

1

1.3

32

Neurofibroma

1

1.3

30

Pons cavernous hemangioma

1

1.3

54

TOTAL

78

100

rate was 88.5% and this outcome was consistent with
literature data. However, it is not easy to access detailed
information in the above-mentioned studies that may
affect contentedness independently. The patients were
asked about the complaints of pain, tearing, redness, sense
of foreign body, loss of visual acuity, artificial tear usage,
and the lack of eye closing ability during daytime and sleep
as well as aesthetical appearance. They chose one of the
following answers for each question (symptom): highly
dissatisfied, dissatisfied, normal, satisfied, and highly
satisfied.
In our questionnaire, we found the highest satisfaction
in visual acuity. Sonmez et al. claim that the visual
acuity is related to the degree of pain and tearing [7]. In
agreement with that argument, we think that the high
rate of satisfaction regarding the visual acuity in our
study is associated with the high satisfaction rates in the
complaints of pain and tearing. For the absence of pain,
tearing, and redness, pleasantness (satisfied or highly
satisfied) was expressed by 92.3%, 87.2%, and 88.5% of the
patients, respectively. Moreover, no patients suffered loss
of visual acuity in the present study. Pickford reported loss
of vision in 15% of the patients with high rates of tearing
and soreness complaints [10]. In our practice, when the
facial nerve damage was permanent or no quick recovery
was expected after a surgery, we performed the gold weight
implantation in the early postoperative period before
discharge. Sharon et al. reported that 25% of the corneal

complications occurred in 18 days and 50% occurred in 2
months after lateral skull base surgery and recommended
early administration of lid loading procedures, preferably
during hospital stay [1]. The low rates of pain, redness, and
tearing in the present study may be related to this principle.
For instance, gold weight implantation was performed 26.6
days on average after acoustic neuroma surgery and 3.2
days on average after temporal zone malignancy surgery.
In our study, 1.3% of the patients were highly dissatisfied
and 7.7% were dissatisfied with cosmetic appearance and
the main reason was the visibility of the implant. Rofagha
reported the rate of cosmetic dissatisfaction to be 5% in
her study and claimed that this was related to placing
the implant too low near the lid margin [13]. However,
to provide eye closing in supine position we preferred to
place the implant close to the lid margin. In our study,
only 3.8% of the patients were not pleased with eye closing
ability during sleep. Placing the implant low with respect
to the lid margin harms the aesthetic appearance. On the
other hand, a superiorly placed implant needs to be heavier
to provide the same gravitational force [7]. For aesthetic
appearance, the rate of highly satisfied or satisfied patients
was 82% in the present study. Pickford et al. assessed the
effects of lid loading on overall facial appearance and
noted that 60% of the patients stated the appearance was
improved [10].
In our study, the most dissatisfying issue was the
necessity of artificial tear usage on a continuous basis.
In our clinical practice, we strictly recommend using
artificial tears every two hours during the day even if a
proper voluntary eye closure is obtained. The disturbance
of tear production and loss of blinking reflex are still major
triggers for corneal complications. As Sharon et al. stated,
intensive corneal lubrication regimen is the single most
important preventive strategy for maintaining corneal
integrity [1].
Lavy et al. observed that foreign body sensation may
occur even after a successful implantation procedure
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Product-Limit Survival Fit
Survival Plot
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Figure 1. Kaplan–Meier survival plot for subjects whose gold weight implant was
removed after a successful facial reanimation procedure

Product-Limit Survival Fit
Survival Plot
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Figure 2. Kaplan–Meier survival plot for subjects who complicated with the
extrusion of the gold weight implant

[14]. The dissatisfaction rate concerning the foreign
body sensation was also low in our study and none of the
patients requested removal of the gold weight because
of this complaint. Using an implant with a curve that
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matches the shape of the eye globe may reduce foreign
body sensation. The flexible implants may be an option
to provide a more suitable shape, but their usefulness is
controversial in the literature. A recent study reported that
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Table 5. Complications.
Complications

n

%

Migration

4

5.1

Infection

4

5.1

Extrusion

10

12.8

Residual Lagophthalmos

2

2.6

Ectropion/Entropion

1

1.3

TOTAL

21

26.9

flexible implants had a higher extrusion rate compared to
that of rigid implants [15]. On the other hand, Braun et al.
reported a low complication rate, high satisfaction level,
and improvement in the quality of life with the platinum
chain implants [16].
Similar to other questionnaire studies, some patients
did not have an implant at the time of the phone call
because it had already been removed due to complications
or recovery [9,10]. While 15.7% of the patients had no
implant in the questionnaire study by Mısra et al., this rate
was 48.7% (n = 38) at the time of the phone call in our
study. Our clinic has a neuro-otology department and we
often implement a dynamic facial reanimation procedure
for patients, especially for those with an operative
cause. In our study, 52.6% of the removal operations
were carried out after employment of a successful facial
reanimation procedure such as 7–12 anastomosis (n = 13),
decompression (n = 4), and nerve repair with cable graft
(n = 3). After facial nerve decompression, recovery was
the fastest with a mean time of 4.75 ± 3.6 (2–10) months.
As expected, it took longer with 18.3 ± 8.2 (3–31) months
on average to obtain a voluntary eye closure after 7–12
cranial nerve transfer. More than half of the removals due
to recovery occurred within one year.
As reported in the literature, surgery is the main
indication for eyelid loading in the majority of patients. In
a study including 76 patients, 46% of subjects underwent
acoustic neuroma surgery and 26% had other surgeries
[9]. In the present study, 93.5% of subjects had an
operational cause and the most common one was acoustic
neuroma with 44.9%. Thus, in an attempt to control the
main pathologies during follow-up, magnetic resonance
imaging (MRI) is important for these patients who had
facial palsy as a consequence of tumors. The presence of
the implant is not contraindicated to MRI [17,18]. We did
not encounter a problem with MRI in our study.
Aggarwal et al. excluded in their study the patients
who had prior gold weight implantation or lid surgery
[19]. Rofagha and Pickford claimed that previous eyelid
surgery increases the risk of complications [10,13]. In a
comprehensive satisfaction questionnaire study involving

76 patients, subjects with previous surgeries and revisions
were not excluded [9]. We excluded the patients with
a previous surgery that may have caused a scar in the
upper lid, resulting in a total number of 78 patients in
the present study. Consistent with the literature, the rate
of complication was 26.9% in our study [7,14,20]. Kelley
et al. observed a higher complication rate of 68% and
claimed that extrusion of the prosthesis (43%) was the
most prevalent complication that often occurred a long
time after insertion (follow-up time: 18 years) [12]. The
rates of extrusion presented in the literature range between
0% and 43% [3,12,14,21,22]. Many studies reported
lower extrusion rates within shorter follow-up periods.
Extrusion was also the most common complication in
our study and the rate was 12.8%. Follow-up time was
74.5 months and the average duration for the extrusion of
the implant was 20.4 ± 20.4 (4–72) months in our study.
Moreover, nearly 80% of this complication occurred
within 2 years. Kelley et al. claim that the risk of extrusion
is reduced by choosing the smallest weight necessary,
placing it deeply through a medial incision, and fixing it
to tarsal plate and recommend that in case of extrusion,
it may be removed and replaced with a smaller weight
[12]. The migration rate in our study was 5.1%. Misra et
al. observed medial shift of the gold weight in 15 of 76
patients (19.7%) [9]. In the literature, it is suggested as the
safest and optimal method to fix the implant to the tarsal
plate after transverse supratarsal incision [7,9,10,12]. Since
the fixation procedure was applied to all patients included
in our study, it was not possible to assess whether or not
the fixation was protected from complications, especially
from migration. Infection is another complication that
entails serious consideration. Antibiotic treatment should
be employed in case of an infection but even after a proper
antibiotherapy, removal of the implant may be required.
Furthermore, if a noninfectious inflammatory response to
implant is suspected, corticosteroids could be administered
but removal of the implant still remains an option [23,24].
In our case series, we removed two implants due to
infection nonresponsive to the antibiotics. We did not
encounter any hypersensitivity reaction to the implants
in the patients. Residual lagophthalmos and ptosis are the
recognized complications of this method and avoidance
these complications depends on accurate estimation of the
weight [3,9]. The rates of these complications reported in
the literature range between 2%–30% [14, 19,20,25,26].
We carefully measured the optimal gold weight in all
patients; thus these complications were quite rare in the
present study. We encountered residual lagophthalmos in
only two (2.6%) patients.
The gold weight implantation is an effective,
satisfactory, reversible, and easily applied procedure and
it significantly reduces expected complaints related to
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paralytic lagophthalmos. Almost all of the requirements
for eyelid loading stem from a surgical procedure and
the most common one is acoustic neuroma surgery.
Implementation of the implant as early as possible may
be more beneficial to protect the patient from ocular
complications. Applying an intensive corneal lubrication
regimen was the most common complaint of patients in
our study. It is noteworthy that the implant was removed
in almost half of the patients. For the vast majority of these
patients, the reason was that they had undergone a dynamic
facial nerve recovery operation that eliminated weight use.
The other reason was complications. The most commonly
performed recovery technique was the 7–12 cranial nerve

transfer and the most widespread complication was
extrusion. The complication rates increased with long
follow-up periods.
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